Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 273

1.

Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score.

Carbone M, Nardi A, Flack S, Carpino G, Varvaropoulou N, Gavrila C, Spicer A, Badrock J, Bernuzzi F, Cardinale V, Ainsworth HF, Heneghan MA, Thorburn D, Bathgate A, Jones R, Neuberger JM, Battezzati PM, Zuin M, Taylor-Robinson S, Donato MF, Kirby J, Mitchell-Thain R, Floreani A, Sampaziotis F, Muratori L, Alvaro D, Marzioni M, Miele L, Marra F, Giannini E, Gaudio E, Ronca V, Bonato G, Cristoferi L, Malinverno F, Gerussi A, Stocken DD, Cordell HJ, Hirschfield GM, Alexander GJ, Sandford RN, Jones DE, Invernizzi P, Mells GF; Italian PBC Study Group and the UK–PBC Consortium.

Lancet Gastroenterol Hepatol. 2018 Jul 12. pii: S2468-1253(18)30163-8. doi: 10.1016/S2468-1253(18)30163-8. [Epub ahead of print]

PMID:
30017646
2.

Support of precision medicine through risk-stratification in autoimmune liver diseases - histology, scoring systems, and non-invasive markers.

Bossen L, Gerussi A, Lygoura V, Mells GF, Carbone M, Invernizzi P.

Autoimmun Rev. 2018 Jul 10. pii: S1568-9972(18)30153-8. doi: 10.1016/j.autrev.2018.02.013. [Epub ahead of print] Review.

PMID:
30005861
3.

Study of the influence of heme oxygenase 1 gene single nucleotide polymorphism (rs2071746) on esophageal varices among patients with cirrhosis.

Ellakany WI, Mahmoud MoheyEldin K, Invernizzi P, Mahmoud ElKady A, Eldin Fathy Abou Elkheir H, Abdel Haleem Abo Elwafa R, Ellakany A.

Eur J Gastroenterol Hepatol. 2018 Aug;30(8):888-892. doi: 10.1097/MEG.0000000000001161.

PMID:
29877949
4.

Transcriptomic analysis and mutational status of IDH1 in paired primary-recurrent intrahepatic cholangiocarcinoma.

Peraldo-Neia C, Ostano P, Cavalloni G, Pignochino Y, Sangiolo D, De Cecco L, Marchesi E, Ribero D, Scarpa A, De Rose AM, Giuliani A, Calise F, Raggi C, Invernizzi P, Aglietta M, Chiorino G, Leone F.

BMC Genomics. 2018 Jun 5;19(1):440. doi: 10.1186/s12864-018-4829-0.

5.

NI-0801, an anti-chemokine (C-X-C motif) ligand 10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acid.

de Graaf KL, Lapeyre G, Guilhot F, Ferlin W, Curbishley SM, Carbone M, Richardson P, Moreea S, McCune CA, Ryder SD, Chapman RW, Floreani A, Jones DE, de Min C, Adams DH, Invernizzi P.

Hepatol Commun. 2018 Mar 23;2(5):492-503. doi: 10.1002/hep4.1170. eCollection 2018 May.

6.

Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2-/- mice and human cholangiocarcinoma tumorigenesis.

Kennedy L, Hargrove L, Demieville J, Karstens W, Jones H, DeMorrow S, Meng F, Invernizzi P, Bernuzzi F, Alpini G, Smith S, Akers A, Meadows V, Francis H.

Hepatology. 2018 Mar 30. doi: 10.1002/hep.29898. [Epub ahead of print]

PMID:
29601088
7.

Clinical and prognostic implications of acute onset of Autoimmune Hepatitis: An Italian multicentre study.

Muratori P, Carbone M, Stangos G, Perini L, Lalanne C, Ronca V, Cazzagon N, Bianchi G, Lenzi M, Floreani A, Invernizzi P, Muratori L.

Dig Liver Dis. 2018 Jul;50(7):698-702. doi: 10.1016/j.dld.2018.02.015. Epub 2018 Mar 2.

PMID:
29567415
8.

Comprehensive review of autoantibodies in patients with hyper-IgM syndrome.

Barbouche MR, Chen Q, Carbone M, Ben-Mustapha I, Shums Z, Trifa M, Malinverno F, Bernuzzi F, Zhang H, Agrebi N, Norman GL, Chang C, Gershwin ME, Invernizzi P.

Cell Mol Immunol. 2018 Feb 5. doi: 10.1038/cmi.2017.140. [Epub ahead of print]

PMID:
29400703
9.

Physiological and technical commitment during a 300-m in-line skating trial in athletes of different age categories.

Invernizzi PL, Scurati R, Crotti M, Bosio A, Longo S, Esposito F.

J Sports Med Phys Fitness. 2018 Jan 4. doi: 10.23736/S0022-4707.18.07942-2. [Epub ahead of print]

PMID:
29308845
10.

Dysregulation of Iron Metabolism in Cholangiocarcinoma Stem-like Cells.

Raggi C, Gammella E, Correnti M, Buratti P, Forti E, Andersen JB, Alpini G, Glaser S, Alvaro D, Invernizzi P, Cairo G, Recalcati S.

Sci Rep. 2017 Dec 15;7(1):17667. doi: 10.1038/s41598-017-17804-1.

11.

Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and Outcome.

Harms MH, Lammers WJ, Thorburn D, Corpechot C, Invernizzi P, Janssen HLA, Battezzati PM, Nevens F, Lindor KD, Floreani A, Ponsioen CY, Mayo MJ, Dalekos GN, Bruns T, Parés A, Mason AL, Verhelst X, Kowdley KV, Goet JC, Hirschfield GM, Hansen BE, van Buuren HR.

Am J Gastroenterol. 2018 Feb;113(2):254-264. doi: 10.1038/ajg.2017.440. Epub 2017 Dec 12.

PMID:
29231188
12.

Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history.

Murillo Perez CF, Goet JC, Lammers WJ, Gulamhusein A, van Buuren HR, Ponsioen CY, Carbone M, Mason A, Corpechot C, Invernizzi P, Mayo MJ, Battezzati PM, Floreani A, Pares A, Nevens F, Kowdley KV, Bruns T, Dalekos GN, Thorburn D, Hirschfield G, LaRusso NF, Lindor KD, Zachou K, Poupon R, Trivedi PJ, Verhelst X, Janssen HLA, Hansen BE; GLOBAL PBC Study Group.

Hepatology. 2018 May;67(5):1920-1930. doi: 10.1002/hep.29717. Epub 2018 Apr 6.

PMID:
29220537
13.

Geoepidemiology of Primary Biliary Cholangitis: Lessons from Switzerland.

Terziroli Beretta-Piccoli B, Stirnimann G, Cerny A, Semela D, Hessler R, Helbling B, Stickel F, Kalid-de Bakker C, Bihl F, Giostra E, Filipowicz Sinnreich M, Oneta C, Baserga A, Invernizzi P, Carbone M, Mertens J.

Clin Rev Allergy Immunol. 2018 Apr;54(2):295-306. doi: 10.1007/s12016-017-8656-x.

PMID:
29181702
14.

Dermatological Complications After Solid Organ Transplantation.

Naldi L, Venturuzzo A, Invernizzi P.

Clin Rev Allergy Immunol. 2018 Feb;54(1):185-212. doi: 10.1007/s12016-017-8657-9. Review.

PMID:
29177692
15.

Female preponderance of primary biliary cholangitis is all about our understanding of its autoimmune nature.

Carbone M, Bonato G, Invernizzi P.

Hepatology. 2018 Apr;67(4):1210-1212. doi: 10.1002/hep.29625. Epub 2018 Feb 19. No abstract available.

PMID:
29091288
16.

From pathogenesis to novel therapies in the treatment of primary biliary cholangitis.

Ronca V, Carbone M, Bernuzzi F, Malinverno F, Mousa HS, Gershwin ME, Invernizzi P.

Expert Rev Clin Immunol. 2017 Dec;13(12):1121-1131. doi: 10.1080/1744666X.2017.1391093. Epub 2017 Nov 9. Review.

PMID:
28994348
17.

Skin Manifestations Associated with Autoimmune Liver Diseases: a Systematic Review.

Terziroli Beretta-Piccoli B, Invernizzi P, Gershwin ME, Mainetti C.

Clin Rev Allergy Immunol. 2017 Dec;53(3):394-412. doi: 10.1007/s12016-017-8649-9. Review.

PMID:
28993983
18.

Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis.

Alberts R, de Vries EMG, Goode EC, Jiang X, Sampaziotis F, Rombouts K, Böttcher K, Folseraas T, Weismüller TJ, Mason AL, Wang W, Alexander G, Alvaro D, Bergquist A, Björkström NK, Beuers U, Björnsson E, Boberg KM, Bowlus CL, Bragazzi MC, Carbone M, Chazouillères O, Cheung A, Dalekos G, Eaton J, Eksteen B, Ellinghaus D, Färkkilä M, Festen EAM, Floreani A, Franceschet I, Gotthardt DN, Hirschfield GM, Hoek BV, Holm K, Hohenester S, Hov JR, Imhann F, Invernizzi P, Juran BD, Lenzen H, Lieb W, Liu JZ, Marschall HU, Marzioni M, Melum E, Milkiewicz P, Müller T, Pares A, Rupp C, Rust C, Sandford RN, Schramm C, Schreiber S, Schrumpf E, Silverberg MS, Srivastava B, Sterneck M, Teufel A, Vallier L, Verheij J, Vila AV, Vries B, Zachou K; International PSC Study Group, The UK PSC Consortium, Chapman RW, Manns MP, Pinzani M, Rushbrook SM, Lazaridis KN, Franke A, Anderson CA, Karlsen TH, Ponsioen CY, Weersma RK.

Gut. 2018 Aug;67(8):1517-1524. doi: 10.1136/gutjnl-2016-313598. Epub 2017 Aug 4.

PMID:
28779025
19.

A functional characteristic of cysteine-rich protein 61: Modulation of myeloid-derived suppressor cells in liver inflammation.

Zhang H, Lian M, Zhang J, Bian Z, Tang R, Miao Q, Peng Y, Fang J, You Z, Invernizzi P, Wang Q, Gershwin ME, Ma X.

Hepatology. 2018 Jan;67(1):232-246. doi: 10.1002/hep.29418. Epub 2017 Nov 17.

PMID:
28777871
20.

HLA haplotypes in primary sclerosing cholangitis patients of admixed and non-European ancestry.

Henriksen EKK, Viken MK, Wittig M, Holm K, Folseraas T, Mucha S, Melum E, Hov JR, Lazaridis KN, Juran BD, Chazouillères O, Färkkilä M, Gotthardt DN, Invernizzi P, Carbone M, Hirschfield GM, Rushbrook SM, Goode E; UK-PSC Consortium, Ponsioen CY, Weersma RK, Eksteen B, Yimam KK, Gordon SC, Goldberg D, Yu L, Bowlus CL, Franke A, Lie BA, Karlsen TH.

HLA. 2017 Oct;90(4):228-233. doi: 10.1111/tan.13076. Epub 2017 Jul 11.

PMID:
28695657

Supplemental Content

Loading ...
Support Center